The efficiency of LIF-05 in blocking access to the LIFR for other cytokines was proven by the finding that STAT as well as ERK activation in response to both, LIF itself as well as hOSM is strongly impaired upon pretreatment of rat hepatoma cells with LIF-05 (Fig. 3C). The gene discussed is LIFR; the disease is hepatocellular carcinoma.